| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/16/2001 | EP1098666A2 Water-soluble drugs and methods for their production |
| 05/16/2001 | EP1098664A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 05/16/2001 | EP1098663A1 Slow release formulations comprising anionic polysaccharide |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | EP1098657A1 Composition for treating obesity and aesthetic treatment method |
| 05/16/2001 | EP1098655A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 05/16/2001 | EP1098654A1 Antilipemic composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098653A2 Subcutaneous medroxyprogesterone acetate for contraception |
| 05/16/2001 | EP1098652A2 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| 05/16/2001 | EP1098651A2 Novel urokinase inhibitors |
| 05/16/2001 | EP1098650A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof |
| 05/16/2001 | EP1098649A1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 05/16/2001 | EP1098648A1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 05/16/2001 | EP1098647A1 Compounds and compositions for treating tissue ischemia |
| 05/16/2001 | EP1098646A1 Stabilized carvedilol injection solution |
| 05/16/2001 | EP1098645A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/16/2001 | EP1098644A1 Substituted benzimidazole antiviral agents |
| 05/16/2001 | EP1098643A2 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 05/16/2001 | EP1098642A1 Methods for treating conditions modulated by lactosylceramide |
| 05/16/2001 | EP1098641A1 Chemically induced intracellular hyperthermia |
| 05/16/2001 | EP1098640A1 Anti-ulcer composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098639A1 Use of a glucose uptake enhancer for reducing apoptosis |
| 05/16/2001 | EP1098638A1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 05/16/2001 | EP1098637A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 05/16/2001 | EP1098636A1 A wet granulation method for preparing a stable pharmaceutical formulation |
| 05/16/2001 | EP1098635A1 Enteric coated pharmaceutical tablet and method of manufacturing |
| 05/16/2001 | EP1098634A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 05/16/2001 | EP1098633A1 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
| 05/16/2001 | EP1098631A1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/16/2001 | EP1098630A2 Composition for enhancing epidermal lipid production |
| 05/16/2001 | EP1098626A2 Method for regulating hair growth |
| 05/16/2001 | EP1098610A1 Biodegradable compositions for the controlled release of encapsulated substances |
| 05/16/2001 | EP1011673B1 Novel niddm regimen |
| 05/16/2001 | EP1011647A4 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 05/16/2001 | EP0996437B1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 05/16/2001 | EP0994948B1 Tgf beta rii receptor nucleic sequence, coded peptide, and uses |
| 05/16/2001 | EP0994706A4 Method and compositions for administering taxanes orally to human patients |
| 05/16/2001 | EP0982990A4 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 05/16/2001 | EP0941089B1 Use of anti-microtubule agents for treating or preventing multiple sclerosis |
| 05/16/2001 | EP0882719B1 Arylethenesulfonamide derivatives and drug composition containing the same |
| 05/16/2001 | EP0879274B1 Technical di- and triglyceride mixtures |
| 05/16/2001 | EP0859766B1 Chiral methyl phenyl oxazolidinones |
| 05/16/2001 | EP0842165B1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 05/16/2001 | EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/16/2001 | EP0695300B1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 05/16/2001 | CN1295677A Methods and apparatus for accelerated orthokeratology |
| 05/16/2001 | CN1295617A Variants of angiogenic factor vascular endothelial cell growth factor: VEGF |
| 05/16/2001 | CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein |
| 05/16/2001 | CN1295576A Process for purification of cephalosporin derivative |
| 05/16/2001 | CN1295575A Novel process for fermentative production of cephalosporin |
| 05/16/2001 | CN1295574A Porphyrins and their use as photosensitizer |
| 05/16/2001 | CN1295573A Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 05/16/2001 | CN1295572A Salt of paroxetine |
| 05/16/2001 | CN1295571A PDE IV inhibiting pyridine derivatives |
| 05/16/2001 | CN1295568A Method for separating a tocotrienol from tocol-containing mixture and compositions thereof |
| 05/16/2001 | CN1295567A Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 05/16/2001 | CN1295566A Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections |
| 05/16/2001 | CN1295565A Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 05/16/2001 | CN1295564A HIV inhibiting pyrimidine derivatives |
| 05/16/2001 | CN1295563A 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 05/16/2001 | CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/16/2001 | CN1295560A C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 05/16/2001 | CN1295559A C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists |
| 05/16/2001 | CN1295558A Novel local anesthetic compounds and uses |
| 05/16/2001 | CN1295548A Novel tricyclic compound |
| 05/16/2001 | CN1295482A Antagonists of the inflammatory mediator oncostatin M (OSM) |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295478A Novel galanic formulation of meloxicam for oral administration |
| 05/16/2001 | CN1295476A 眼用组合物 Ophthalmic compositions |
| 05/16/2001 | CN1295475A Medicine for improving optic disc circulation |
| 05/16/2001 | CN1295474A Method for stabilizing pharmaceutical composition by special use of antioxidant |
| 05/16/2001 | CN1295473A Use of dexmedetomidine for ICU sedation |
| 05/16/2001 | CN1295472A Carbediolo-galenics |
| 05/16/2001 | CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 05/16/2001 | CN1295470A Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof |
| 05/16/2001 | CN1295467A Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 05/16/2001 | CN1295466A Process for manufacture of (sub) micron sized particles by dissolving in compressed gas and surfactants |
| 05/16/2001 | CN1295465A Quinolone-containing liposome composition |
| 05/16/2001 | CN1295464A Solid, quick dissolving cetirizine fomulation |
| 05/16/2001 | CN1295463A Fizzy formulation |
| 05/16/2001 | CN1295462A Peroral active agent suspension |
| 05/16/2001 | CN1295461A Anti-enzyme composition comprising ethylenediamine disuccinic acid |
| 05/16/2001 | CN1295460A Polyalkoxy copolymers as lipase inhibitors and their composition |
| 05/16/2001 | CN1295456A Acidified composition for topical treatment of nail and skin conditions |
| 05/16/2001 | CN1295078A Antisense thio-oligonucleic acid of target protein kinase C-alpha and its medicine composition and application in treating cancer |
| 05/16/2001 | CN1295077A Intermediate of ganglioside GM3 analogue using fluorine to substitute sialic acid at 9-position |
| 05/16/2001 | CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof |
| 05/16/2001 | CN1295071A Condensed imidezo-[1,2-a] pyridines |
| 05/16/2001 | CN1295070A Process for prep. of 1-type sodium-hydrogen exchange agent inhibitor |
| 05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
| 05/16/2001 | CN1295064A Novel tricyclic compound and medicine composition containing the same |
| 05/16/2001 | CN1295060A Intermediate for preparing allyl quinone derivative and prep. of the same |
| 05/16/2001 | CN1294928A Sobering-up tea and its making process |
| 05/16/2001 | CN1294920A Jianfuling medicine for skin disease and its compounding process |
| 05/16/2001 | CN1294919A Cough treating medicine and its preparation |
| 05/16/2001 | CN1294917A Specific oral liquid for treating various gastroenteristic diseases and its preparation |
| 05/16/2001 | CN1294915A Medicine powder for treating beri-beri, smelly foot and sweaty foot |
| 05/16/2001 | CN1294914A Drug composition for treatment and prevention of hepatopathy |
| 05/16/2001 | CN1294913A Pharmaceutical use of compound |